We are live on ! Find out more
MC

Matisse Capital Portfolio holdings

AUM $234M
1-Year Est. Return 19.72%
This Fund
S&P 500
This Quarter Est. Return
+2.59%
1 Year Est. Return
+19.72%
3 Year Est. Return
+52.07%
5 Year Est. Return
+45.94%
10 Year Est. Return
+148.24%
AUM
$111M
AUM Growth
-$15M
Cap. Flow
-$17.1M
Cap. Flow %
-15.34%
Top 10 Hldgs %
34.54%
Holding
133
New
12
Increased
28
Reduced
61
Closed
13
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MAN icon
126
ManpowerGroup
MAN
$2.58B
-2,880
Closed -$248K
MASI
127
DELISTED
Masimo
MASI
-2,070
Closed -$202K
MO icon
128
Altria Group
MO
$125B
-4,999
Closed -$284K
NAD icon
129
Nuveen Quality Municipal Income Fund
NAD
$2.73B
-10,525
Closed -$140K
SAGE
130
DELISTED
Sage Therapeutics
SAGE
-2,500
Closed -$391K
AKP
131
DELISTED
Alliance Californa Muni Fd
AKP
-12,100
Closed -$159K
EVP
132
DELISTED
Eaton Vance Pennsylvania Municipal Income Trust
EVP
-13,342
Closed -$151K
EIA
133
DELISTED
Eaton Vance California Municipal Bond II Shares of Ben. Int.
EIA
-14,729
Closed -$158K

Similar funds

Matisse Capital's Q3 2018 Portfolio in Review

As of Q3 2018, Matisse Capital held 133 positions worth $111M, down 12% from $126M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Matisse Capital withdrew a net $17.1M in Q3 2018, closing 13 positions and reducing 61 holdings. Its most notable exit was Sage Therapeutics, an estimated $391K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 4.8% of assets, up from 3.6% a quarter earlier, followed by Real Estate and Technology.

Against the trend, Matisse Capital opened a new position in Nuveen Arizona Quality Municipal Income Fund worth $1.25M.

  • Matisse Capital's largest Q3 2018 buy was Nuveen Arizona Quality Municipal Income Fund: 107,024 shares worth $1.25M.
  • Matisse Capital added most to BlackRock New York Municipal Income Trust II in Q3 2018, an estimated $643K increase.
  • Matisse Capital's biggest Q3 2018 reduction was Central Securities Corp, cutting an estimated $3.8M.
  • Matisse Capital fully exited Sage Therapeutics in Q3 2018, selling an estimated $391K.
  • Matisse Capital's ten largest holdings make up 35% of its $111M portfolio in Q3 2018.
  • Matisse Capital opened 12 new positions and closed 13 in Q3 2018.
  • Matisse Capital's portfolio value fell 12% quarter-over-quarter to $111M.

Based on Matisse Capital's 13F filing for Q3 2018, filed 30 Oct 2018.